Literature DB >> 10027918

Human, rat, and mouse kidney cells express functional erythropoietin receptors.

C Westenfelder1, D L Biddle, R L Baranowski.   

Abstract

BACKGROUND: Erythropoietin (EPO), secreted by fibroblast-like cells in the renal interstitium, controls erythropoiesis by regulating the survival, proliferation, and differentiation of erythroid progenitor cells. We examined whether renal cells that are exposed to EPO express EPO receptors (EPO-R) through which analogous cytokine responses might be elicited.
METHODS: Normal human and rat kidney tissue and defined cell lines of human, rat, and mouse kidney were screened, using reverse transcription-polymerase chain reaction, nucleotide sequencing, ligand binding, and Western blotting, for the expression of EPO-R. EPO's effects on DNA synthesis and cell proliferation were also examined.
RESULTS: EPO-R transcripts were readily detected in cortex, medulla, and papilla of human and rat kidney, in mesangial (human, rat), proximal tubular (human, mouse), and medullary collecting duct cells (human). Nucleotide sequences of EPO-R cDNAs from renal cells were identical to those of erythroid precursor cells. Specific 125I-EPO binding revealed a single class of high- to intermediate-affinity EPO-Rs in each tested cell line (kD 96 pm to 1. 4 nm; Bmax 0.3 to 7.0 fmol/mg protein). Western blots of murine proximal tubular cell membranes revealed an EPO-R protein of approximately 68 kDa. EPO stimulated DNA synthesis and cell proliferation dose dependently.
CONCLUSION: This is the first direct demonstration, to our knowledge, that renal cells possess EPO-Rs through which EPO stimulates mitogenesis. This suggests currently unrecognized cytokine functions for EPO in the kidney, which may prove beneficial in the repair of an injured kidney while being potentially detrimental in renal malignancies.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10027918     DOI: 10.1046/j.1523-1755.1999.055003808.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  56 in total

Review 1.  Molecular mechanisms of ischemic preconditioning in the kidney.

Authors:  Pinelopi P Kapitsinou; Volker H Haase
Journal:  Am J Physiol Renal Physiol       Date:  2015-08-26

Review 2.  Erythropoietic agents and the elderly.

Authors:  Neeraj Agarwal; Josef T Prchal
Journal:  Semin Hematol       Date:  2008-10       Impact factor: 3.851

3.  The anti-inflammatory effect of erythropoietin and melatonin on renal ischemia reperfusion injury in male rats.

Authors:  Nasser Ahmadiasl; Shokofeh Banaei; Alireza Alihemmati; Behzad Baradaran; Ehsan Azimian
Journal:  Adv Pharm Bull       Date:  2013-12-23

4.  Prognostic significance of left ventricular hypertrophy observed at dialysis initiation depends on the pre-dialysis use of erythropoiesis-stimulating agents.

Authors:  Terumasa Hayashi; Tomonori Kimura; Keiko Yasuda; Yoshitsugu Obi; Koichi Sasaki; Kenichiro Iio; Kenro Miyasato; Taro Kamimura; Harumi Kitamura; Yoshiharu Tsubakihara; Hiromi Rakugi; Yoshitaka Isaka
Journal:  Clin Exp Nephrol       Date:  2012-10-26       Impact factor: 2.801

5.  Cytoprotective doses of erythropoietin or carbamylated erythropoietin have markedly different procoagulant and vasoactive activities.

Authors:  Thomas R Coleman; Christof Westenfelder; Florian E Tögel; Ying Yang; Zhuma Hu; Leanne Swenson; Henri G D Leuvenink; Rutger J Ploeg; Livius V d'Uscio; Zvonimir S Katusic; Pietro Ghezzi; Adriana Zanetti; Kenneth Kaushansky; Norma E Fox; Anthony Cerami; Michael Brines
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-03       Impact factor: 11.205

6.  The cellular origin and proliferative status of regenerating renal parenchyma after mercuric chloride damage and erythropoietin treatment.

Authors:  T-H Yen; M R Alison; H T Cook; R Jeffery; W R Otto; N A Wright; R Poulsom
Journal:  Cell Prolif       Date:  2007-04       Impact factor: 6.831

7.  Protection against cisplatin-induced nephrotoxicity by recombinant human erythropoietin.

Authors:  Suayib Yalcin; Sevda Müftüoğlu; Eren Cetin; Banu Sarer; Berna Akkuş Yildirim; Dilara Zeybek; Bülent Orhan
Journal:  Med Oncol       Date:  2003       Impact factor: 3.064

8.  A novel role for erythropoietin during fibrin-induced wound-healing response.

Authors:  Zishan A Haroon; Khalid Amin; Xiaohong Jiang; Murat O Arcasoy
Journal:  Am J Pathol       Date:  2003-09       Impact factor: 4.307

9.  An integrative genomics approach identifies Hypoxia Inducible Factor-1 (HIF-1)-target genes that form the core response to hypoxia.

Authors:  Yair Benita; Hirotoshi Kikuchi; Andrew D Smith; Michael Q Zhang; Daniel C Chung; Ramnik J Xavier
Journal:  Nucleic Acids Res       Date:  2009-06-02       Impact factor: 16.971

Review 10.  Erythropoietic stress and anemia in diabetes mellitus.

Authors:  Dhruv K Singh; Peter Winocour; Ken Farrington
Journal:  Nat Rev Endocrinol       Date:  2009-04       Impact factor: 43.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.